Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guiding GC1008 treatment of primary brain tumors by 89Zr-GC1008 PET imaging
2010-021639-15Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fresolimumab in glioma, sponsored by University Medical Center Groningen. Primary endpoint: Part I primary endpoint. Started Sep 2010; status: active.
02
Drugs
fresolimumab
03
Conditions
glioma
Beyond the preview
Go deeper on 2010-021639-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021639-15.